A Phase II Randomized, Double-Blinded, Placebo-Controlled Parallel Group Trial To Examine The Efficacy And Safety Of BI 425809 Once Daily With Adjunctive Computerized Cognitive Training Over 12 Week Treatment Period In Patients With Schizophrenia

Project: Research

Project Description

NMA HREC Reference Number: HREC 283/18 Project ID: 48825
NMA SSA Reference Number: SSA/48825/MonH-2019-176112(v1)
Monash Health Ref: RES-19-0000-412X
StatusActive
Effective start/end date25/06/19 → 24/06/24
View all
View less

Keywords

  • clinical trial
  • treatment efficacy
  • cognitive disorders
  • schizophrenia